SCD Use to Prevent Deep Venous Thrombosis (DVT) in Patients With PICC Lines
| Status: | Terminated |
|---|---|
| Conditions: | Cardiology, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/11/2018 |
| Start Date: | August 2012 |
| End Date: | October 13, 2016 |
Sequential Pneumatic Compression to Prevent PICC-related Upper Extremity Venous Thrombosis in Critically Ill Neurological Patients
The purpose of this study is to see if a compression device on the arm where a peripherally
inserted central catheter (PICC) line has been inserted can prevent the formation of a blood
clot around the PICC line.
inserted central catheter (PICC) line has been inserted can prevent the formation of a blood
clot around the PICC line.
In a pilot prospective randomized controlled trial, consecutive patients requiring placement
of a PICC line in the Neuroscience intensive care unit were randomly assigned to either the
SCD (intervention) group or a non SCD (control) group.
Standardized vascular access patency protocols was used in all enrolled patients. All
patients had an indwelling 5 French, double lumen PICC unless additional venous access was
required by the primary service. Patients randomized to the intervention arm had an SCD
placed in the arm with the PICC within 24 hours of PICC placement.
Five to seven days after placement of the PICC, the patients were examined with venous duplex
ultrasound of the upper extremity to assess for the presence of venous thrombosis. The
patients also had the ultrasound again 12-14 days post insertion if the PICC was kept for
more than 10 days. If the PICC line was removed before 5-7 days, an upper extremity
ultrasound was obtained upon PICC removal. In case of suspected symptomatic venous
thromboembolism, the investigations were performed according to current practice standards.
Data collection was be considered complete upon removal of the PICC line.
of a PICC line in the Neuroscience intensive care unit were randomly assigned to either the
SCD (intervention) group or a non SCD (control) group.
Standardized vascular access patency protocols was used in all enrolled patients. All
patients had an indwelling 5 French, double lumen PICC unless additional venous access was
required by the primary service. Patients randomized to the intervention arm had an SCD
placed in the arm with the PICC within 24 hours of PICC placement.
Five to seven days after placement of the PICC, the patients were examined with venous duplex
ultrasound of the upper extremity to assess for the presence of venous thrombosis. The
patients also had the ultrasound again 12-14 days post insertion if the PICC was kept for
more than 10 days. If the PICC line was removed before 5-7 days, an upper extremity
ultrasound was obtained upon PICC removal. In case of suspected symptomatic venous
thromboembolism, the investigations were performed according to current practice standards.
Data collection was be considered complete upon removal of the PICC line.
Inclusion Criteria:
- Subject's age is greater than or equal to 18 years
- Subject is patient in neuro intensive care unit at time of PICC placement
Exclusion Criteria:
- Acute trauma to the upper extremity harboring the PICC
- Current use of prophylactic anticoagulation
- Inability to fit the SCD on the arm because of arm size
- Documented previous upper extremity DVT in the arm harboring the PICC line
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
